Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 4Lymphoid 4Thoracic 3Plasma cell 3Genitourinary 3Classical hematology 3Breast 3Gastrointestinal 2Sarcoma 1Myeloid 1Head & Neck 1Gynecologic 1CNS 1

Conditions

Brain Neoplasms 405Glioma 261Glioblastoma 204Central Nervous System Neoplasms 92Neoplasms 87Neuroblastoma 82Astrocytoma 72Neurofibromatosis 1 55Breast Neoplasms 52Meningioma 51Lung Neoplasms 42Oligodendroglioma 39Head and Neck Neoplasms 35Medulloblastoma 33Spinal Cord Neoplasms 30Sarcoma 30Leukemia 30Paraganglioma 29Pheochromocytoma 28Lymphoma 28Carcinoma, Non-Small-Cell Lung 27Prostatic Neoplasms 24Neuroma, Acoustic 24Ependymoma 24Melanoma 22Recurrence 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Ovarian Neoplasms 20Neoplasm Metastasis 19Lymphoma, Non-Hodgkin 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Thromboembolism × CNS × Clear all
NCT00253669 2018-06-28

Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Completed
110 enrolled
CNSSarcoma

Astrocytoma, Glioblastoma, Oligodendroglioma, Thromboembolism, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡